Health Update Bahamas: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Update Bahamas.

September 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

October 2025

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

Press releases published on November 20, 2025

November 20, 2025

Sol-Gel Reports Third Quarter 2025 Financial Results and Provides Corporate Updates

GlobeNewswire

November 20, 2025

CapVest recapitalizes Curium to accelerate its growth strategy, marking the largest transaction in nuclear medicine globally

GlobeNewswire

November 20, 2025

Ocugen CEO to Present at NobleCon21—Noble Capital Markets’ Twenty-First Annual Emerging Growth Equity Conference

GlobeNewswire

November 20, 2025

Psyence BioMed Reaches Major Breakthrough in Pharmaceutical-Grade Ibogaine Supply for Worldwide Clinical and Therapeutic Markets

GlobeNewswire

November 20, 2025

Acuitive Technologies introduces Citregraft, a unique bone graft substitute designed to bind proteins and enhance regeneration

GlobeNewswire

November 20, 2025

Axsome Therapeutics to Participate in Upcoming Investor Conferences

GlobeNewswire

November 20, 2025

Sagimet Biosciences to Participate in the 8th Annual Evercore ISI Healthcare Conference

GlobeNewswire

November 20, 2025

Applied Therapeutics Announces Corporate Updates

GlobeNewswire

November 20, 2025

Gain Therapeutics Presents Preclinical GT-02287 Data at Neuroscience 2025

GlobeNewswire

November 20, 2025

MediWound Reports Third Quarter 2025 Financial Results and Provides Corporate Update

GlobeNewswire

November 20, 2025

Can-Fite’s CF602 Erectile Dysfunction Treatment Receives Notice of Patent Allowance in Brazil

GlobeNewswire

November 20, 2025

SciSparc: Neurothera Labs Announces Israeli Patent Application in Collaboration with Clearmind Medicine for Novel Non-Hallucinogenic Neuroplastogen Treatment for Depression

GlobeNewswire

November 20, 2025

Boehringer Ingelheim obtains two EU CVMP positive opinions for avian influenza vaccines VAXXITEK® HVT+IBD+H5 and VAXXINACT® H5

GlobeNewswire

November 20, 2025

Clearmind Medicine Accelerate FDA-Approved Alcohol Use Disorder Clinical Trial by Activating Fifth Elite Global Medical Site

GlobeNewswire

November 20, 2025

Consommation de cannabis et d’alcool chez les personnes aînées : et si nous ouvrions le dialogue ?

GlobeNewswire

November 20, 2025

RadNet’s DeepHealth Announces Wichita Radiological Group as First Operations Suite™ Customer

GlobeNewswire

November 20, 2025

4th Edition of bioMérieux Canada Symposium: Over 300 Canadian Health Experts Unite in Toronto to Tackle the Growing Threat of Antimicrobial Resistance

GlobeNewswire

November 20, 2025

Maple Report: Only 15 percent of Canadian family caregivers say the health-care system meets their needs all the time

GlobeNewswire

November 20, 2025

Alvotech and Advanz Pharma Receive Marketing Approval Across the European Economic Area for Gobivaz®, a First-in-Market Biosimilar to Simponi® (golimumab)

GlobeNewswire

November 20, 2025

Concept Life Sciences Presents New Data Advancing Neuroinflammation and Neurodegeneration Research at Neuroscience 2025

GlobeNewswire